/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Professor Hilgendorf works as an interventional cardiologist and deputy medical director at Germany’s largest University Heart Center at Freiburg-Bad Krozingen. He leads the high-risk outpatient clinic and engages in clinical trials in the field of lipid therapy, heart failure, immunomodulation, and coronary and structural heart disease. Following his postdoctoral training at the MGH Center for Systems Biology, Boston, MA, USA, he established his own research group in Freiburg, Germany, studying the role of the innate and adaptive immune system in cardiovascular disease and the impact of traditional and non-traditional risk factors. Based on his seminal work, Ingo Hilgendorf was appointed Heisenberg Professor for Immunocardiology at the University of Freiburg, Germany.
